Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPSK3169A in Coronary Heart Disease or High Risk Patients
NCT01609140Phase 2Completed
- Sponsor
- Genentech
- Start
- May 2012
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of RG-7652 in hypercholesterolemia, sponsored by Genentech. Started May 2012; status: completed.
02
Drugs
RG-7652
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01609140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609140.